NYC · American Strategic Investment Co. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | - | $0 | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - |
| SG&A | $8.27M | $9.22M | $9.38M | $12.49M | $8.70M | $7.57M |
| Total Operating Expenses | $86.74M | $182.51M | $149.81M | $90.95M | $90.61M | $85.50M |
| D&A | $12.82M | $18.41M | $26.53M | $28.67M | $31.06M | $31.75M |
| Operating Income | $4.40M | ($121.22M) | ($87.10M) | ($26.95M) | ($20.39M) | ($22.61M) |
| Interest Expense | $15.28M | $19.49M | $18.86M | $18.92M | $19.09M | $19.14M |
| Income Tax | $0 | - | $0 | $0 | $0 | - |
| Net Income | ($21.19M) | ($140.59M) | ($105.92M) | ($45.90M) | ($39.47M) | ($40.96M) |
| EPS - Basic | ($8.32) | ($56.51) | ($47.57) | ($26.59) | ($3.21) | - |
| EPS - Diluted | ($8.32) | ($56.51) | ($47.57) | ($26.59) | ($3.21) | - |
Balance Sheet
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.30M | $9.78M | $5.29M | $9.21M | $11.67M | $31.00M |
| Accounts Receivable | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Accounts Payable | - | - | - | - | - | - |
| Current Assets | - | - | - | - | - | - |
| Total Assets | $445.16M | $507.07M | $694.17M | $790.46M | $823.05M | $861.85M |
| Current Liabilities | - | - | - | - | - | - |
| Long-term Debt | - | - | - | - | - | - |
| Total Liabilities | $380.40M | $421.48M | $469.38M | $468.88M | $471.92M | $480.28M |
| Stockholders' Equity | $64.76M | $85.59M | $224.79M | $301.06M | $338.99M | $377.56M |
| Retained Earnings | ($667.06M) | ($645.87M) | ($505.28M) | ($399.36M) | ($350.71M) | ($305.88M) |
Cash Flow
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | ($7.75M) | ($4.00M) | ($7.41M) | ($486.0K) | ($7.92M) | ($13.58M) |
| Investing Cash Flow | ($3.79M) | $59.86M | $71.0K | ($5.55M) | ($3.38M) | ($3.75M) |
| Financing Cash Flow | $650.0K | ($49.73M) | $4.03M | ($6.27M) | ($275.0K) | ($970.0K) |
| CapEx | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - |
Ratios
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | - | - | - | - | - | - |
| Operating margin | - | - | - | - | - | - |
| EBITDA margin | - | - | - | - | - | - |
| Net margin | - | - | - | - | - | - |
| Free cash flow margin | - | - | - | - | - | - |
| FCF / Net income | - | - | - | - | - | - |
| R&D / Revenue | - | - | - | - | - | - |
| SG&A / Revenue | - | - | - | - | - | - |
| Effective tax rate | - | - | - | - | - | - |
| Return on assets | -4.8% | -27.7% | -15.3% | -5.8% | -4.8% | -4.8% |
| Return on equity | -32.7% | -164.3% | -47.1% | -15.2% | -11.6% | -10.8% |
| Return on invested capital | - | - | - | - | - | - |
| Liquidity | ||||||
| Current ratio | - | - | - | - | - | - |
| Quick ratio | - | - | - | - | - | - |
| Cash ratio | - | - | - | - | - | - |
| Leverage | ||||||
| Debt / Equity | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - |
| Interest coverage | 0.3x | -6.2x | -4.6x | -1.4x | -1.1x | -1.2x |
| Equity multiplier | 6.87 | 5.92 | 3.09 | 2.63 | 2.43 | 2.28 |
| Liabilities / Assets | 0.85 | 0.83 | 0.68 | 0.59 | 0.57 | 0.56 |
| Efficiency | ||||||
| Asset turnover | - | 0.00 | - | - | - | - |
| Inventory turnover | - | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - | - |
| Days inventory outstanding | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - |
| Valuation | ||||||
| P / E | - | - | - | - | - | - |
| P / B | 0.3x | 0.2x | 0.1x | 0.0x | 0.4x | - |
| P / S | - | - | - | - | - | - |
| EV / EBITDA | 1.2x | - | - | -3.6x | 11.6x | - |
| Growth | ||||||
| Revenue growth (YoY) | - | - | - | - | - | - |
| Revenue CAGR (3y) | - | - | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - |
| Gross profit growth (YoY) | - | - | - | - | - | - |
| Operating income growth (YoY) | - | -39.2% | -223.3% | -32.2% | 9.8% | -305.2% |
| Net income growth (YoY) | 84.9% | -32.7% | -130.8% | -16.3% | 3.7% | -87.1% |
| EPS growth (YoY) | 85.3% | -18.8% | -78.9% | -728.3% | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - |
| Book value growth (YoY) | -24.3% | -61.9% | -25.3% | -11.2% | -10.2% | -10.2% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2020-12-31.
Product / service
$100.0K totalTenant Reimbursement And Other Revenue$100.0K · 100.0%
Stability scores
Piotroski F-score
FY 2025 · 9-point quality
2/9
Weak
- ✗Net income positive
- ✗Operating cash flow positive
- ✓ROA improved YoY
- ✓Cash flow > net income
- -Long-term debt decreased
- -Current ratio improved
- ✗No share dilution
- -Gross margin improved
- -Asset turnover improved
Peer comparison
Same SIC group: Real Estate Investment Trusts
Comparing American Strategic Investment Co. against the 5 most active filers in the same SIC group.
Dividends
$0.00/share trailing 12 months
| Ex-date | Per share |
|---|---|
| Apr 8, 2022 | $0.8000 |
| Jan 12, 2022 | $0.8000 |
| Oct 8, 2021 | $0.8000 |
| Jul 9, 2021 | $0.8000 |
| Apr 9, 2021 | $0.8000 |
| Jan 8, 2021 | $0.8000 |
| Oct 8, 2020 | $0.3920 |